As salinomycin has been previously identified as a cancer stem cell growth inhibitor (Gupta et al, 2009), we studied whether salinomycin reduces ALDH activity in VCaP and LNCaP prostate cancer cells. Here, LDHA is linked to prostate carcinoma.